Tuesday, November 28, 2023

#Biotech Review $XBI

Biotech Review
Trading noise, the random movement of price over the short term, does not control trends, cycles, and profits. The majority, an emotionally driven group focused solely on price, often interprets it as meaningful information. This leads to confusion, frustration, missed opportunities, and leaves the majority as the bag holders of trend transitions. The Evolution of the Trade helps investors stand separate from the majority.

The Biotechnology's overall trend, revealed by trends of price, leverage, and time, are defined in The Matrix for subscribers.

Subscriber Comments

The Economy & Stocks Report, a series of videos, extends the discussion for stocks.

Biotechnology ($XBI), a leadership group in the Nasdaq 100, went from hero to zero from 2020 to 2023. Every die-hard biotech supporter has been fried like an egg on hot Georgia asphalt. Very few bulls exist.

The Evolution of the Trade, a process that follows the primary and composite trend, energy within the framework of cycles, is defined by the (1) Energy Build or Nibble, (2) Primary Trend Breakout or Flip, (3) Alignment & Energy or Reset, and (4) Primary Trend Decline or Aging Trend.

Biotechnology $XBI is an excellent candidate for a report in 2024, despite the clear lack of interest from the majority. It's time to watch $XBI.

Use your Subscription Level Access Code to access the full review.

Follow me on Twitter or Facebook for further discussion.


Market-driven money flow, trend, and intermarket analysis is provided by an Access Key.